• Users Online: 385
  • Print this page
  • Email this page

  Reader Comments

Year : 2021 | Volume:  32 | Issue Number:  3

ORIGINAL ARTICLE

Outcomes of starting low-dose pazopanib in patients with metastatic renal cell carcinoma who do not meet eligibility criteria for clinical trials

Akatsuka Jun, Kimura Go, Obayashi Kotaro, Tsutsumi Kotaro, Yanagi Masato, Endo Yuki, Takeda Hayato, Hayashi Tatsuro, Toyama Yuka, Suzuki Yasutomo, Hamasaki Tsutomu, Yamamoto Yoichiro, Kondo Yukihiro

Add Your Comments
 
No one has added comments on this article. Click here to add your remarks


 

Back To Article